New round of financing led by Vensana Capital will support technology platform expansion and further validating VX1, Volta’s Artificial Intelligence (AI) Decision-Support Software in improving catheter ablation for complex cardiac arrhythmias Medical device executive John Slump joins as Chief Financial Officer MARSEILLE, France, Jan. 05, 2023 (GLOBE NEWSWIRE) — Volta […]
Tag: Volta Medical
Volta Medical’s AI based solution for patients in atrial fibrillation achieves robust validation in first peer-reviewed publication
Volta VX1 decision support software reproduces expert-physician electrogram (EGM) analysis that can assist physicians in the real-time identification of specific abnormal electrograms in a persistent atrial fibrillation (AF) population After a one-year follow-up, patients demonstrated a high freedom from atrial fibrillation and from any atrial arrhythmia, 89% and 73% after […]
Volta Medical VX1 AI Software to be Featured at Heart Rhythm 2022
– Company’s VX1 AI software for use in atrial fibrillation will be featured during several events at the Congress – MARSEILLE, France and PROVIDENCE, R.I., April 27, 2022 (GLOBE NEWSWIRE) — Volta Medical, a pioneering medtech startup advancing novel artificial intelligence (AI) algorithms to treat cardiac arrhythmias, today announced it […]
First U.S. patients with persistent cardiac arrythmias treated using Volta Medical’s artificial intelligence-based analysis
Novel, FDA-cleared and CE-certified medical device is designed to help cardiologists identify cardiac abnormalities in patients undergoing ablation treatment for persistent, drug-resistant atrial fibrillation (AF), a common heart condition. New York-Presbyterian Queens, Northwell Health’s Lenox Hill Hospital, New York City, and Ascension St. Vincent’s Riverside, Jacksonville, Fla. are the first […]
VOLTA MEDICAL expands its hospital network in France as part of an international multicenter study with its VX1 artificial intelligence software in cardiology
For the treatment, in the operating room, of atrial fibrillation, the most complex and most common arrhythmia in the world 11 French research centers have already joined the study in 2021 The first results will be published in Q3 2023 MARSEILLE, France – ( BUSINESS WIRE ) – Volta Medical, an innovative […]
VOLTA MEDICAL raises 28 million USD to revolutionize persistent AFib ablation
MARSEILLE, France, Jan. 5, 2021 /PRNewswire/ — Volta Medical, a pioneering French-based HealthTech startup, working on novel artificial intelligence (AI) algorithms to treat cardiac arrythmias, today announced that it has successfully raised 28 million USD. The financing round was led by Gilde Healthcare with participation of existing shareholder Pasteur Mutualité. The new capital will […]
VOLTA MEDICAL’s VX1 AI software for use in atrial fibrillation mapping now FDA cleared
MARSEILLE, France, Dec. 9, 2020 /PRNewswire/ — Volta Medical, a pioneering French-based HealthTech startup is pleased to announce that it has obtained FDA clearance for its revolutionary VX1 AI (artificial intelligence) software. This is the first FDA clearance for an AI based tool in interventional cardiac electrophysiology. VX1 is a machine and deep […]



